ACUPUNCTURE & ELECTRO-THERAPEUTICS RES., INT. J., Vol. 46, pp. 1-97, 2021 Copyright ©2021 Cognizant Communication Corp. Printed in the USA. 0360-1293/21 $60.00 + .00 https://doi.org/10.3727/036012921X16128784949502 BDORT Evaluation in COVID-19 Cases: Researching Severity Markers and Predictive Indexes PRADO P de A., MD Master in General Surgery; Acupuncture and Integrative Medicine Specialist; Director of AMBBDORT; Head of the Integrative Medicine Outpatient Clinic of ACL Foundation IWASA, S, M.D., Orthopedist, F.I.C.A.E, Cert. ORT-MD (4 Dan) *; Specialist Integrative Medicine; President ACL Foundation (in São Paulo, SP, Brazil) (Correspondence: [email protected]) Summary Background The number of patients with COVID-19 is increasing dramatically worldwide. Early recognition of severe forms is essential for the timely screening of patients. Various laboratory parameters are used to assess the severity of the disease and rational screening. Low lymphocyte counts and serum levels of CRP, D-dimers, ferritin, cardiac Troponin I, and IL-6 are often used in risk stratification to predict severe and fatal COVID-19. But the number of biomarkers investigated for this purpose is enormous, which proves that this is an unresolved problem. The evaluation by BDORT can contribute enormously to the early identification of severity and is superior to conventional laboratory assessment. It is necessary to advance this line of investigation because there is a significant gap in the medical literature on this subject. Methods Thirty patients with suspected symptoms of COVID-19 or who had contact with contaminants were evaluated. As evaluations were carried out on photos of the patients. The viral load of SARS-CoV-2 and sixty-nine Reference Control Substances (RCS) were measured. The resonance phenomenon between identical substances is widely used in BDORT and we use it working from microscopic images of the etiologic agent to estimate viral load. Presence and rate of arteritis and the occurrence of contamination by Prevotella and Porphyromonas were also evaluated. The evaluation of patients at a distance through photos is not a strange practice to BDORT and during the pandemic, it becomes a valuable resource to respect social distance. The evaluation is made on printed photos and description of imagings, parameter measurements and selection of drugs are noted in these photos. Clinical decision and patient follow-up were based on these measurements and their evolutionary course. Findings Among the evaluated parameters that proved to be severity markers were viral load, arteritis rate, IL-6, PCR, Integrin , Thromboxane B2, DHEA, CPK, Homocysteine, BNP, ANP, PAI, Troponin, contamination by Prevotella and Porphyromonas, rate of subclinical infection by other etiologic agents, acetylcholine. Interpretation In addition to imaging patterns and drug selection, the measurement of biomarkers performed Delivered by Ingenta by BDORT shows IP:a rational 192.168.39.210 convergence On: with Mon, conventional1 04 Oct 2021 medical 16:44:19 knowledge, but goes Article(s)beyond and/or it. BDORT figure(s)-oriented cannot treatment be used addsfor resale. tremendous Please value use to proper the treatment citation of format COVID when-19 citing becausethis article it ensures including safe theand DOI,early publisherclinical decisions reference, adjusted volume online number over time. and page location. References 1) Systematic review with meta-analysis of the accuracy of diagnostic tests for COVID-19 Beatriz Böger et al BDORT Evaluation in COVID-19 Cases: Researching Severity Markers and Predictive Indexes PRADO P de A., MD Master in General Surgery; Acupuncture and Integrative Medicine Specialist; Director of AMBBDORT; Head of the Integrative Medicine Outpatient Clinic of ACL Foundation IWASA, S, M.D., Orthopedist, F.I.C.A.E, Cert. ORT-MD (4 Dan) *; Specialist Integrative Medicine; President ACL Foundation (in São Paulo, SP, Brazil) (Correspondence: [email protected]) Summary Background The number of patients with COVID-19 is increasing dramatically worldwide. Early recognition of severe forms is essential for the timely screening of patients. Various laboratory parameters are used to assess the severity of the disease and rational screening. Low lymphocyte counts and serum levels of CRP, D-dimers, ferritin, cardiac Troponin I, and IL-6 are often used in risk stratification to predict severe and fatal COVID-19. But the number of biomarkers investigated for this purpose is enormous, which proves that this is an unresolved problem. The evaluation by BDORT can contribute enormously to the early identification of severity and is superior to conventional laboratory assessment. It is necessary to advance this line of investigation because there is a significant gap in the medical literature on this subject. Methods Thirty patients with suspected symptoms of COVID-19 or who had contact with contaminants were evaluated. As evaluations were carried out on photos of the patients. The viral load of SARS-CoV-2 and sixty-nine Reference Control Substances (RCS) were measured. The resonance phenomenon between identical substances is widely used in BDORT and we use it working from microscopic images of the etiologic agent to estimate viral load. Presence and rate of arteritis and the occurrence of contamination by Prevotella and Porphyromonas were also evaluated. The evaluation of patients at a distance through photos is not a strange practice to BDORT and during the pandemic, it becomes a valuable resource to respect social distance. The evaluation is made on printed photos and description of imagings, parameter measurements and selection of drugs are noted in these photos. Clinical decision and patient follow-up were based on these measurements and their evolutionary course. Findings Among the evaluated parameters that proved to be severity markers were viral load, arteritis rate, IL-6, PCR, Integrin , Thromboxane B2, DHEA, CPK, Homocysteine, BNP, ANP, PAI, Troponin, contamination by Prevotella and Porphyromonas, rate of subclinical infection 2 ABSTRACTS OF THE 36TH ANNUAL SYMPOSIUM by other etiologic agents, acetylcholine. Interpretation In addition to imaging patterns and drug selection, the measurement of biomarkers performed by BDORT shows a rational convergence with conventional medical knowledge, but goes beyond it. BDORT-oriented treatment adds tremendous value to the treatment of COVID-19 because it ensures safe and early clinical decisions adjusted online over time. References 1) Systematic review with meta-analysis of the accuracy of diagnostic tests for COVID-19 BeatrizAmerican Böger Journal et al of American Infection JournalControl of 000 Infection (2020) Control1-9 000 (2020) 1-9 https://doi.org/10.1016/j.ajic.2020.07.011 https://doi.org/10.1016/j.ajic.2020.07.011 2) Mild versus Severe2) MildCOVID versus-19: SevereLaboratory COVID Markers-19: Laboratory Markers Velavan, T. P. et al .Velavan, International T. P. et Journal al. International of Infectious Journal Diseases of InfectiousVol 95, June Diseases 2020, Vol 95, June 2020, Pages 304-307 Pageshttps://doi.org/10.1016/j.ijid.2020.04.061 304-307 https://doi.org/10.1016/j.ijid.2020.04.061 3) Diagnostic significance3) Diagnostic of SARS significance-CoV-2 IgM of positive/IgGSARS-CoV- 2negative IgM positive/IgG antibody profile negative in antibody profile in symptomatic patientssymptomatic with suspected patie COVIDnts with-19 suspected testing negativeCOVID -by19 RTtesting-PCR negative by RT-PCR Arantxa Valdivia et Arantxaal. Journal Valdivia of Infection et al. Journal- Available of Infection online 25 - AvailableAugust 2020 online 25 August 2020 https://doi.org/10.1016/j.jinf.2020.08.028https://doi.org/10.1016/j.jinf.2020.08.028 4) C-reactive protein4) levels C-reactive in the protein early stage levels of inCOVID the early-19 stage of COVID-19 L.Wang. MédecineL.Wang et Maladies. Médecine Infectieuses et Maladies. Volume Infectieuses 50, Issue. 4, Volume June 2020, 50, PagesIssue 4, June 2020, Pages 332-334 https://doi.org/332-33410.1016/j.medmal.2020.03.007 https://doi.org/10.1016/j.medmal.2020.03.007 5) Prognostic value 5)of Prognosticinterleukin -value6, C- reactiveof interleukin protein,-6, andC-reactive procalcitonin protein, in and patients procalcitonin with in patients with COVID-19 COVID-19 Fang Liu et al. JournalFang Liu of Cliniet al.cal VirologyJournal of Volume Clinical 127, Virology June 2020, Volume 104370 127, June 2020, 104370 https://doi.org/10.1016/j.jcv.2020.104370https://doi.org/10.1016/j.jcv.2020.104370 6) Rapid Screening 6)and Rapid Diagnosis Screening of Various and Diagnosis Cancers offrom Various Human Cancers Voice fromUsing Human Bi-Digital Voice Using Bi-Digital O-Ring Test ResonanceO-Ring Phenomenon Test Resonance Between Phenomenon 2 Identical Between Substances 2 Identical i.e. Between Substances i.e. Between Microscope Slide ofMicrosco Specific peCancer Slide Tissueof Specific & Cancer Cancer Information Tissue & Cancerin the Sound Information of in the Sound of Human Voice, and DetectionHuman Voice, of Myocardial and Detection Damage of Myocardial & Infection Damage from Human & Infection Voice from Human Voice Author: Omura, YoshiakiAuthor: Omura, Yoshiaki Source: AcupunctureSource: & Electro Acupuncture-Therapeutics & Electro Research,-Therapeutics Volume 32, Research, Numbers Volume 3-4, 2007, 32, Numbers 3-4, 2007, pp. 235-269(35) pp.Publisher: 235-269(35) Cognizant Publisher: Communication Cognizant Corporation Communication Corporation DOI: https://doi.org/10.3727/036012907815844066